Characteristics | Number of patients (% of total) | Prescription of inj. AS in complied doses; n (%) | Co-prescription of ACT | # (%) of prescriptions that complied with WHO recommendation* | ||
---|---|---|---|---|---|---|
< 3 doses | 3 doses | > 3 doses | n (%) | n (%); [95% CI] | ||
Sex | ||||||
Female | 582 (48.9) | 41 (7.0) | 492 (84.5) | 49 (8.4) | 178 (30.6) | 153 (26.3); [22.9, 30.0] |
Male | 609 (51.1) | 43 (7.1) | 526 (86.4) | 40 (6.6) | 196 (32.2) | 176 (28.9); [25.4, 32.6] |
Age (years) | ||||||
Median (IQR) | 3.9 (2, 9) | |||||
5+ | 476 (40.0) | 33 (6.9) | 386 (81.9) | 57 (12.0) | 119 (25.0) | 101 (21.2); [17.8, 25.1] |
Under 5 | 712 (59.7) | 50 (7.0) | 630 (88.5) | 32 (4.5) | 254 (35.7) | 227 (31.9); [28.6, 35.4] |
Missing | 3 (0.3) | 1 (33.3) | 2 (66.7) | 0 (0) | 1 (33.3) | |
Weight (kg) | ||||||
Median (IQR) | 13 (10, 20) | |||||
< 10 | 276 (23.2) | 19 (6.9) | 246 (89.1) | 11 (4.0) | 89 (32.3) | 85 (30.8); [25.6, 36.5] |
10–19 | 510 (42.8) | 35 (6.9) | 450 (88.2) | 25 (4.9) | 191 (37.5) | 163 (32.0); [28.0, 36.1] |
20–29 | 111 (9.3) | 8 (7.2) | 96 (86.5) | 7 (6.3) | 32 (28.8) | 29 (26.1); [18.8, 35.1] |
30+ | 200 (16.8) | 14 (7.0) | 149 (74.5) | 37 (18.5) | 23 (11.5) | 16 (8.0); [4.9, 12.7] |
Missing | 94 (7.9) | 8 (8.5) | 77 (81.9) | 9 (9.6) | 39 (41.5) | |
Country | ||||||
Ghana | 391 (32.8) | 31 (7.9) | 355 (90.8) | 5 (1.3) | 336 (85.9) | 301 (77.0); [72.3, 80.9] |
Uganda | 800 (67.2) | 53 (6.6) | 663 (82.9) | 84 (10.5) | 38 (4.8) | 28 (3.5); [2.4, 5.0] |
Total | 1191 (100) | 84 (7.1) | 1018 (85.5) | 89 (7.5) | 374 (31.4) | 329 (27.6); [25.2, 30.2] |